Skip to main content
SpringerLink
Log in

Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Amyopathic dermatomyositis is a rare, idiopathic, connective tissue disease that presents with dermatologic lesions of classic dermatomyositis but lacks the myopathy of this disease. Cutaneous manifestations may include Gottron’s sign, heliotrope rash, and characteristic patterns of poikiloderma. There is a substantial risk for developing interstitial lung disease or malignancy in patients with amyopathic dermatomyositis. A literature review of amyopathic dermatomyositis was performed using the PubMed medical database. The key features of amyopathic dermatomyositis, including autoantibodies, clinical presentation and dermatologic manifestations, epidemiology, history, associated malignancies, management, and pathogenesis, are summarized in this review. Cancer (solid tumor) (73/79, 89 %) and hematologic malignancies (9/79, 11 %) were reported in 79 patients, with three patients having more than one malignancy. In addition, there were six patients with amyopathic dermatomyositis who had tumor of unknown primary, and eight patients with cancer-associated amyopathic dermatomyositis for whom no additional details were provided. From the group of 73 tumors for whom primary origin and sex were available, malignancy of the genitourinary organs (24/73, 33 %), aerorespiratory organs (15/73, 21 %), and breast (14/73, 19 %) were the most commonly observed solid organ tumors. Tumors of the genitourinary organs (15/48, 31 %) and breast (14/48, 29 %) were the most frequent neoplasms in women, accounting for 29 of 48 (60 %) cancers, with the most common sites being breast (14/48, 29 %), ovary (8/48, 17 %), and cervix or uterus (5/48, 10 %). In men, tumors of the aerorespiratory (9/25, 36 %) and genitourinary (9/25, 36 %) tracts were the most common neoplasms, accounting for 72 % (18/25) of cancers; the most common sites of primary malignancy were nasopharyngeal (6/25, 24 %), bladder (4/25, 16 %), and either colorectal, lung or prostate cancer (three cancers each, 12 %). In summary, the search for an undiagnosed associated malignancy in patients with amyopathic dermatomyositis should focus towards the organs most frequently affected. Similar to classic dermatomyositis, ovarian and nasopharyngeal cancers are also common in amyopathic dermatomyositis. However, in contrast to lung cancer, which is the most frequent malignancy associated with classic dermatomyositis, breast cancer was the most common type of malignancy reported in patients with amyopathic dermatomyosotis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ghazi E, Sontheimer RD, Werth VP. The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol. 2013;31(1):128–34.

    PubMed  Google Scholar 

  2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.

    Article  CAS  PubMed  Google Scholar 

  3. Rockerbie NR, Woo TY, Callen JP, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 1989;20(4):629–32.

    Article  CAS  PubMed  Google Scholar 

  4. Reeder MJ, Wetter DA, Li X, Davis M. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Dermatol Clin. 2010;146(1):26–30.

    Google Scholar 

  5. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597–613.

    Article  PubMed  Google Scholar 

  6. Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol. 2007;57(6):937–43.

    Article  PubMed  Google Scholar 

  7. Bailey EE, Fiorentino DF. Amyopathic dermatomyositis: definitions, diagnosis, and management. Curr Rheumatol Rep. 2014;16(12):465.

    Article  PubMed  Google Scholar 

  8. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24(6 Pt 1):959–66.

    Article  CAS  PubMed  Google Scholar 

  9. El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46(4):560–5.

    Article  PubMed  Google Scholar 

  10. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003;61(3):288–9.

    Article  PubMed  Google Scholar 

  11. van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316–21.

    Article  PubMed  Google Scholar 

  12. Bronner IM, Linssen WHJP, van der Meulen MFG, Hoogendijk JE, de Visser M. Polymyositis: an ongoing discussion about a disease entity. Arch Neurol. 2004;61(1):132–5.

    Article  PubMed  Google Scholar 

  13. Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD. A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol. 2007;157(4):637–44.

    Article  CAS  PubMed  Google Scholar 

  14. Ortigosa LCM, dos Reis VMS. Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo. Brazil. An Bras Dermatol. 2014;89(5):719–27.

    Article  PubMed  Google Scholar 

  15. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7.

    Article  CAS  PubMed  Google Scholar 

  16. Callen JP. Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep. 2010;12(3):192–7.

    Article  PubMed  Google Scholar 

  17. Takahashi Y, Murota H, Tarutani M, Sano S, Okinaga T, Tominaga K, et al. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis? Allergol Int. 2010;59(4):425–8.

    Article  PubMed  Google Scholar 

  18. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–82.

    Article  CAS  PubMed  Google Scholar 

  19. Eichenfield DZ, Paravar T. Zebra stripes in dermatomyositis: case report and review of flagellate erythema-associated dermatomyositis. J Eur Acad Dermatol Venereol. 2016. doi:10.1111/jdv.13582.

    PubMed  Google Scholar 

  20. Pau-Charles I, Moreno PJ, Ortiz-Ibáñez K, Lucero MC, Garcia-Herrera A, Espinosa G, et al. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy. J Eur Acad Dermatol Venereol. 2014;28(8):1097–102.

    Article  CAS  PubMed  Google Scholar 

  21. Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013;14(4):291–313.

    Article  PubMed  Google Scholar 

  22. Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677–85.

    Article  PubMed  Google Scholar 

  23. van der Kooi AJ, de Visser M. Idiopathic inflammatory myopathies. Handb Clin Neurol. 2014;119:495–512.

    Article  PubMed  Google Scholar 

  24. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464–74.

    Article  PubMed  Google Scholar 

  25. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006;45(Suppl 4):iv18–21.

    Google Scholar 

  26. Kubo N, Sawayama Y, Okada K, Nakagawa Y, Asou Y, Nabeshima S, et al. A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation [in Japanese]. Ryūmachi. 2002;42(4):676–81.

    PubMed  Google Scholar 

  27. Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38(10):973–9.

    Article  CAS  PubMed  Google Scholar 

  28. Nofal A, El-Din ES. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? Int J Dermatol. 2012;51(5):535–41.

    Article  PubMed  Google Scholar 

  29. Adili AF, Liaconis H, Gusenbauer K, Kapoor A. Renal cell carcinoma and amyopathic dermatomyositis. Can Urol Assoc J. 2015;9(5–6):E340–2.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol. 2013;2013:509354.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. DM4-Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.

    Article  CAS  PubMed  Google Scholar 

  32. Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol. 2015;1–14. doi:10.1007/s12016-015-8511-x.

  33. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363–7.

    Article  CAS  PubMed  Google Scholar 

  34. Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969–71.

    Article  PubMed  Google Scholar 

  35. Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009;31(1):61–7.

    Article  PubMed  Google Scholar 

  36. Tansley S, Gunawardena H. The evolving spectrum of polymyositis and dermatomyositis—moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol. 2014;47(3):264–73.

    Article  PubMed  Google Scholar 

  37. Chinoy H, Lamb JA, Ollier WER, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011;13(3):216.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, Trallero-Araguás E, Balada E, Vilardell-Tarrés M, et al. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis. 2012;71(6):993–6.

    Article  CAS  PubMed  Google Scholar 

  39. Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22(6):639–43.

    Article  PubMed  Google Scholar 

  40. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147(4):391–8.

    Article  CAS  PubMed  Google Scholar 

  41. Muro Y, Ishikawa A, Sugiura K, Akiyama M. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies. Rheumatology (Oxford). 2012;51(8):1508–13.

    Article  CAS  Google Scholar 

  42. Ogawa M, Sugiura K, Yokota K, Muro Y, Akiyama M. Anti-transcription intermediary factor 1-γ antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer. J Eur Acad Dermatol Venereol. 2016;30(2):373–5.

    Article  CAS  PubMed  Google Scholar 

  43. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for dermatomyositis. American academy of dermatology. J Am Acad Dermatol. 1996;34(5 Pt 1):824–9.

    CAS  PubMed  Google Scholar 

  44. Lam WWM, Chan H, Chan YL, Fung JWK, So NMC, Metreweli C. MR imaging in amyopathic dermatomyositis. Acta Radiol. 1999;40(1):69–72.

    Article  CAS  PubMed  Google Scholar 

  45. Stonecipher MR, Jorizzo JL, White WL, Walker FO, Prichard E. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis? J Am Acad Dermatol. 1993;28(6):951–6.

    Article  CAS  PubMed  Google Scholar 

  46. Dawkins MA, Jorizzo JL, Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38(3):397–404.

    Article  CAS  PubMed  Google Scholar 

  47. Cosnes A, Amaudric F, Gherardi R, Verroust J, Wechsler J, Revuz J, et al. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 1995;131(12):1381–5.

    Article  CAS  PubMed  Google Scholar 

  48. Goyal S, Nousari HC. Paraneoplastic amyopathic dermatomyositis associated with breast cancer recurrence. J Am Acad Dermatol. 1999;41(5 Pt 2):874–5.

    Article  CAS  PubMed  Google Scholar 

  49. Mebazaa A, Boussen H, Nouira R, Gamoudi A, Rahal K, Kamoun MR, et al. Dermatomyositis and breast cancer: a multicenter Tunisian retrospective study of 13 cases. La Tunisie médicale. 2011;89(1):18–22.

    PubMed  Google Scholar 

  50. Yasar S, Gurleyik G, Sabuncuoglu Y, Aktekin A, Yasar B, Serdar ZA. Paget’s disease of the breast in a patient with amyopathic dermatomyositis. Case Rep Med. 2012;2012(C):1–4.

    Google Scholar 

  51. Blanes M, Bañuls J, Yuste A, Adrover E, Pascual JC, Pastor N, et al. Amyopathic dermatomyositis associated with a recurrence of breast cancer. Actas Dermo-Sifiliográficas. 2005;96(5):299–302.

    Article  PubMed  Google Scholar 

  52. Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Clin Rheumatol. 2007;26(7):1198–200.

    Article  PubMed  Google Scholar 

  53. Pusceddu V, Frau B, Guerzoni D, Catani G, Murgia M, Murru M, et al. Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer. Breast J. 2008;14(6):591–2.

    Article  PubMed  Google Scholar 

  54. Park SH, Kum YS, Kim KC, Choe JY, Park SH, Kim SK. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29(10):1231–5.

    Article  PubMed  Google Scholar 

  55. Fung JWK, Chan HL, Lam WWM. Amyopathic dermatomyositis in Hong Kong—association with nasopharyngeal carcinoma. Int J Dermatol. 1998;37(9):659–63.

    Article  CAS  PubMed  Google Scholar 

  56. Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore. 2000;29(2):219–23.

    CAS  PubMed  Google Scholar 

  57. Whitmore SE, Watson R, Rosenshein NB, Provost TT. Dermatomyositis sine myositis: association with malignancy. J Rheumatol. 1996;23(1):101–5.

    CAS  PubMed  Google Scholar 

  58. Ee HL, Ng PPL, Tan SH. Exacerbation of amyopathic dermatomyositis in Orientals: a high alert for nasopharyngeal carcinoma. Australas J Dermatol. 2004;45(1):77–8.

    Article  PubMed  Google Scholar 

  59. Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009;28(8):979–84.

    Article  PubMed  Google Scholar 

  60. Orme CM, Zhou LH, Lazic T. Clinically amyopathic dermatomyositis in a patient with an extramedullary plasmacytoma of the tongue. J Dermatol. 2012;39(7):656–7.

    Article  PubMed  Google Scholar 

  61. Galimberti F, Li Y, Fernandez AP. Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort. Br J Dermatol. 2016;174(1):158–64.

    Article  PubMed  Google Scholar 

  62. Langan SM, O’Briain S, Barnes L. Dermatomyositis associated with angiotropic lymphoma. Clin Exp Dermatol. 2003;28(6):597–9.

    Article  CAS  PubMed  Google Scholar 

  63. Osman Y, Narita M, Kishi K, Fujiwara H, Fukuda T, Koike T, et al. Case report: amyopathic dermatomyositis associated with transformed malignant lymphoma. Am J Med Sci. 1996;311(5):240–2.

    Article  CAS  PubMed  Google Scholar 

  64. Ledwich LJ, Olenginski TP. A rare lymphoma in a patient with amyopathic dermatomyositis. Am J Clin Dermatol. 2010;11(2):151–5.

    Article  PubMed  Google Scholar 

  65. Requena C, Alfaro A, Traves V, Nagore E, Llombart B, Serra C, et al. Paraneoplastic dermatomyositis: a study of 12 cases. Actas dermo-sifiliográficas. 2014;105(7):675–82.

    Article  CAS  PubMed  Google Scholar 

  66. Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, et al. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus. 2015;4:240.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Uchida A, Sugihara M, Ito S, Nowatari T, Kunikata T, Suzuki T, et al. Ovarian cancer with swelling of the right upper arm, amyopathic dermatomyositis, and elevated serum KL-6. Nihon Naika Gakkai Zasshi. 2006;95(4):742–4.

    Article  PubMed  Google Scholar 

  68. Seidler AM, Wasserman DI, González-Serva A, Konnikov N. Amyopathic dermatomyositis resembling stasis dermatitis. J Am Acad Dermatol. 2008;59(3):515–8.

    Article  PubMed  Google Scholar 

  69. Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21(2):178–83.

    Article  PubMed  Google Scholar 

  70. Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, et al. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res. 2014;2014:290797.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Kita Y. Post-operative acute exacerbation of interstitial pneumonea associated with amyopathic dermatomyositis. Kyobu Geka. 2010;63(7):546–9.

    PubMed  Google Scholar 

  72. Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38(8):1636–43.

    Article  CAS  PubMed  Google Scholar 

  73. Russ BW, English JC, King DH, Halbach DP. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder. Cutis. 1999;63(2):73–6.

    CAS  PubMed  Google Scholar 

  74. Olhoffer IH, Carroll C, Watsky K. Dermatomyositis sine myositis presenting with calcinosis universalis. Br J Dermatol. 1999;141(2):365–6.

    Article  CAS  PubMed  Google Scholar 

  75. Apaydin R, Gül U, Bahadir S, Siviloglu C, Ofluoglu I. Dermatomyositis without muscle weakness associated with transitional cell carcinoma of the bladder. J Eur Acad Dermatol Venereol. 2002;16(2):172–4.

    Article  CAS  PubMed  Google Scholar 

  76. Dunn CL, James WD. The role of magnetic resonance imaging in the diagnostic evaluation of dermatomyositis. Arch Dermatol. 1993;129(9):1104–6.

    Article  CAS  PubMed  Google Scholar 

  77. Finger DR, Dunn CL, Gilliland WR, James WD. Amyopathic dermatomyositis associated with malignancy. Int J Dermatol. 1996;35(9):663–4.

    Article  CAS  PubMed  Google Scholar 

  78. Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, et al. Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today. 2000;30(3):302–4.

    Article  CAS  PubMed  Google Scholar 

  79. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56(4):255–86.

    Article  CAS  Google Scholar 

  80. Celebi S, Gül A, Kamali S, Inanc M, Ocal L, Aral O, et al. Amyopathic dermatomyositis associated with cervical cancer. Clin Rheumatol. 2001;20(6):438–40.

    Article  CAS  PubMed  Google Scholar 

  81. Kikuchi K, Seto Y, Matsubara T, Yamada K, Tamaki K. Amyopathic dermatomyositis associated with esophageal cancer. Int J Dermatol. 2008;47(3):310–1.

    Article  PubMed  Google Scholar 

  82. Nogi S, Hashimoto A, Iwata K, Futami H, Takaoka H, Arinuma Y, et al. Case of immunosuppressant-resistant amyopathic dermatomyositis with rapidly progressive interstitial pneumonia ameliorated after resection of gastric cancer. Japanese J Clin Immunol. 2012;35(3):188–93.

    Article  Google Scholar 

  83. Villers A, Lami M-C, Filoche P, Milinkevitch S, Goujon J-M, Guillet G. Regression of primary melanoma with metastases associated with amyopathic dermatomyositis. Ann Dermatol Venereol. 2006;133(6–7):573–6.

    Article  CAS  PubMed  Google Scholar 

  84. Norrenberg S, Gangji V, Del Marmol V, Soyfoo MS. Diffuse muscular pain, skin tightening, and nodular regenerative hyperplasia revealing paraneoplastic amyopathic dermatomyositis due to testicular cancer. Case Rep Rheumatol. 2012;2012:1–4.

    Article  Google Scholar 

  85. Molina-Ruiz AM, Romero F, Carrasco L, Feltes F, Haro R, Requena L. Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association? Clin Exp Dermatol. 2015;40(8):887–90.

    Article  CAS  PubMed  Google Scholar 

  86. Ritchie SA, Kobayashi T, Sperling L. Amyopathic necrotizing dermatomyositis secondary to an underlying malignancy: a case report and review of the literature. Cutis. 2008;82(6):407–13.

    PubMed  Google Scholar 

  87. Pérez-Pérez LC, Suárez-Amor O, Sánchez-Aguilar D, Ginarte M, Pereiro M, Toribio J. Clinically-amyopathic dermatomyositis: presentation of three cases. Actas Dermo-Sifiliográficas. 2005;96(5):295–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical School, University of California San Diego, San Diego, CA, 92093, USA

    Jeremy Udkoff

  2. Department of Dermatology, University of California San Diego, 10991 Twinleaf Court, San Diego, CA, 92131, USA

    Philip R. Cohen

Authors
  1. Jeremy Udkoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip R. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip R. Cohen.

Ethics declarations

Funding

No funding was received for the preparation of this review.

Conflicts of interest

Jeremy Udkoff and Philip R. Cohen have no conflicts of interest to report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Udkoff, J., Cohen, P.R. Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies. Am J Clin Dermatol 17, 509–518 (2016). https://doi.org/10.1007/s40257-016-0199-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-016-0199-z

Keywords

Search

Navigation